Silvant Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Silvant Capital Management LLC

  • $2.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$25.61 - $110.96 $89,199 - $386,473
-3,483 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$71.26 - $95.75 $69,834 - $93,835
980 Added 39.15%
3,483 $280,000
Q4 2018

Feb 06, 2019
BUY
$48.76 - $76.44 $122,046 - $191,329
2,503 New
2,503 $140,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email